Wallace Eli M. has filed 4 insider transactions across 1 company since August 2025.
Most recent transaction: a grant/award of 1114400 shares of BridgeBio Oncology Therapeutics, Inc. ($BBOT) on January 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 1, 2026 | BridgeBio Oncology Therapeutics, Inc. | $BBOT | Wallace Eli M. | Chief Executive Officer | A | Stock Option (Right to Buy) | 1114400 | $0.00 | 1,114,400.0000 | 79,988,687 | 9999.99% | 1.39% |
| Dec. 10, 2025 | BridgeBio Oncology Therapeutics, Inc. | $BBOT | Wallace Eli M. | Chief Executive Officer | D | Stock Option (Right to Buy) | 1114400 | $0.00 | 500,000.0000 | 79,988,687 | 69.03% | 1.39% |
| Oct. 2, 2025 | BridgeBio Oncology Therapeutics, Inc. | $BBOT | Wallace Eli M. | Chief Executive Officer | A | Stock Option (Right to Buy) | 1614400 | $0.00 | 1,614,400.0000 | 0 | 9999.99% | 0.00% |
| Aug. 26, 2025 | BridgeBio Oncology Therapeutics, Inc. | $BBOT | Wallace Eli M. | Chief Executive Officer | A | Stock Option (Right to Buy) | 499731 | $0.00 | 499,731.0000 | 0 | 9999.99% | 0.00% |